Literature DB >> 12530329

Virally encoded chemokines and chemokine receptors in the role of viral infections.

Peter J Holst1, Hans R Lüttichau, Thue W Schwartz, Mette M Rosenkilde.   

Abstract

Large DNA viruses such as pox- and in particular herpesviruses are notorious in their ability to evade the immune system and to be maintained in the general population. Based on the accumulated knowledge reviewed in this study it is evident that important mechanisms of these actions are the acquisition and modification of host-encoded chemokines and chemokine receptors. The described viral molecules leave nothing to chance and have thoroughly and efficiently corrupted the host immune system. Through this process viruses have identified key molecules in antiviral responses by their inhibition of these or potent ways to alter an efficient antiviral response to a weak Th2-driven response. Examples here are the chemokine scavenging by US28, attractance of Th2 cells and regulatory cells by vMIP1-3 and the selective engaging of CCR8 by MC148. Important insights into viral pathology and possible targets for antiviral therapies have been provided by UL33, UL78 and in particular ORF74 and the chances are that many more will follow. In HHV8 vMIP-2 and the chemokine-binding proteins potent anti-inflammatory agents have been provided. These have already had their potential demonstrated in animal models and may in their native or modified forms represent useful therapies in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12530329     DOI: 10.1159/000068138

Source DB:  PubMed          Journal:  Contrib Microbiol        ISSN: 1420-9519


  6 in total

Review 1.  Viral G Protein-Coupled Receptors Encoded by β- and γ-Herpesviruses.

Authors:  Mette M Rosenkilde; Naotaka Tsutsumi; Julius M Knerr; Dagmar F Kildedal; K Christopher Garcia
Journal:  Annu Rev Virol       Date:  2022-06-07       Impact factor: 14.263

2.  CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated hepatic steatosis.

Authors:  P J Holst; C Orskov; K Qvortrup; J P Christensen; A R Thomsen
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

3.  Structural Diversity in Conserved Regions Like the DRY-Motif among Viral 7TM Receptors-A Consequence of Evolutionary Pressure?

Authors:  Ann-Sofie Mølleskov Jensen; Alexander Hovard Sparre-Ulrich; Nicholas Davis-Poynter; Mette Marie Rosenkilde
Journal:  Adv Virol       Date:  2012-07-30

4.  Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes.

Authors:  Chunfeng Qu; Emmerson W Edwards; Frank Tacke; Véronique Angeli; Jaime Llodrá; Guzman Sanchez-Schmitz; Alexandre Garin; Nasreen S Haque; Wendy Peters; Nico van Rooijen; Carmen Sanchez-Torres; Jonathan Bromberg; Israel F Charo; Steffen Jung; Sergio A Lira; Gwendalyn J Randolph
Journal:  J Exp Med       Date:  2004-11-08       Impact factor: 14.307

5.  Monkeypox virus viral chemokine inhibitor (MPV vCCI), a potent inhibitor of rhesus macrophage inflammatory protein-1.

Authors:  John M Jones; Ilhem Messauodi; Ryan D Estep; Beata Orzechowska; Scott W Wong
Journal:  Cytokine       Date:  2008-07-17       Impact factor: 3.926

6.  Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation.

Authors:  Suzan Fares; Katja Spiess; Emma T B Olesen; Jianmin Zuo; Sarah Jackson; Thomas N Kledal; Mark R Wills; Mette M Rosenkilde
Journal:  mBio       Date:  2019-01-15       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.